These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 35166208

  • 1. Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with gemcitabine on pancreatic cancer.
    Yehya AHS, Asif M, Abdul Majid AMS, Oon CE.
    Biomed J; 2021 Dec; 44(6):694-708. PubMed ID: 35166208
    [Abstract] [Full Text] [Related]

  • 2. Polymolecular botanical drug of Orthosiphon stamineus extract (C5OSEW5050ESA) as a complementary therapy to overcome gemcitabine resistance in pancreatic cancer cells.
    Yehya AHS, Asif M, Abdul Majid AMS, Oon CE.
    J Tradit Complement Med; 2023 Jan; 13(1):39-50. PubMed ID: 36685076
    [Abstract] [Full Text] [Related]

  • 3. Anti-tumour activity and toxicological studies of combination treatment of Orthosiphon stamineus and gemcitabine on pancreatic xenograft model.
    Yehya AHS, Subramaniam AV, Asif M, Kaur G, Abdul Majid AMS, Oon CE.
    World J Gastroenterol; 2022 Aug 28; 28(32):4620-4634. PubMed ID: 36157930
    [Abstract] [Full Text] [Related]

  • 4. Toxicological studies of Orthosiphon stamineus (Misai Kucing) standardized ethanol extract in combination with gemcitabine in athymic nude mice model.
    Yehya AHS, Asif M, Kaur G, Hassan LEA, Al-Suede FSR, Abdul Majid AMS, Oon CE.
    J Adv Res; 2019 Jan 28; 15():59-68. PubMed ID: 30581613
    [Abstract] [Full Text] [Related]

  • 5. Antiobesity and Lipid Lowering Effects of Orthosiphon stamineus in High-Fat Diet-Induced Obese Mice.
    Seyedan A, Alshawsh MA, Alshagga MA, Mohamed Z.
    Planta Med; 2017 May 28; 83(8):684-692. PubMed ID: 27992939
    [Abstract] [Full Text] [Related]

  • 6. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
    Prashanth N, Meghana P, Sandeep Kumar Jain R, Pooja S Rajaput, Satyanarayan N D, Raja Naika H, Kumaraswamy H M.
    Sci Total Environ; 2024 Mar 01; 914():169727. PubMed ID: 38163613
    [Abstract] [Full Text] [Related]

  • 7. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).
    Xia G, Wang H, Song Z, Meng Q, Huang X, Huang X.
    J Exp Clin Cancer Res; 2017 Aug 10; 36(1):107. PubMed ID: 28797284
    [Abstract] [Full Text] [Related]

  • 8. Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism.
    Mohamed EA, Siddiqui MJ, Ang LF, Sadikun A, Chan SH, Tan SC, Asmawi MZ, Yam MF.
    BMC Complement Altern Med; 2012 Oct 08; 12():176. PubMed ID: 23039079
    [Abstract] [Full Text] [Related]

  • 9. Rosmarinic Acid, the Main Effective Constituent of Orthosiphon stamineus, Inhibits Intestinal Epithelial Apoptosis Via Regulation of the Nrf2 Pathway in Mice.
    Cai X, Yang F, Zhu L, Xia Y, Wu Q, Xue H, Lu Y.
    Molecules; 2019 Aug 21; 24(17):. PubMed ID: 31438521
    [Abstract] [Full Text] [Related]

  • 10. Phytochemical analysis of Andrographis paniculata and Orthosiphon stamineus leaf extracts for their antibacterial and antioxidant potential.
    Malahubban M, Alimon AR, Sazili AQ, Fakurazi S, Zakry FA.
    Trop Biomed; 2013 Sep 21; 30(3):467-80. PubMed ID: 24189677
    [Abstract] [Full Text] [Related]

  • 11. SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo.
    Oon CE, Strell C, Yeong KY, Östman A, Prakash J.
    Eur J Pharmacol; 2015 Jun 15; 757():59-67. PubMed ID: 25843411
    [Abstract] [Full Text] [Related]

  • 12. Anticlastogenic, antimutagenic, and cytoprotective properties of Orthosiphon stamineus ethanolic leaves extract.
    Al-Dulaimi DW, Shah Abdul Majid A, M Baharetha H, Ahamed MBK, Faisal SF, Al Zarzour RH, Ein Oon C, Abdul Majid AMS, Ahmed Hassan LE.
    Drug Chem Toxicol; 2022 Mar 15; 45(2):641-650. PubMed ID: 32321321
    [Abstract] [Full Text] [Related]

  • 13. Phytochemical profile of Orthosiphon aristatus extracts after storage: Rosmarinic acid and other caffeic acid derivatives.
    Chua LS, Lau CH, Chew CY, Ismail NIM, Soontorngun N.
    Phytomedicine; 2018 Jan 15; 39():49-55. PubMed ID: 29433683
    [Abstract] [Full Text] [Related]

  • 14. Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.
    El Amrani M, Corfiotti F, Corvaisier M, Vasseur R, Fulbert M, Skrzypczyk C, Deshorgues AC, Gnemmi V, Tulasne D, Lahdaoui F, Vincent A, Pruvot FR, Van Seuningen I, Huet G, Truant S.
    Mol Carcinog; 2019 Nov 15; 58(11):1985-1997. PubMed ID: 31373074
    [Abstract] [Full Text] [Related]

  • 15. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
    Cao J, Yang J, Ramachandran V, Arumugam T, Deng D, Li Z, Xu L, Logsdon CD.
    PLoS One; 2015 Nov 15; 10(12):e0144969. PubMed ID: 26709920
    [Abstract] [Full Text] [Related]

  • 16. Pancreatic cancer in vitro toxicity mediated by Chinese herbs SPES and PC-SPES: implications for monotherapy and combination treatment.
    Schwarz RE, Donohue CA, Sadava D, Kane SE.
    Cancer Lett; 2003 Jan 10; 189(1):59-68. PubMed ID: 12445678
    [Abstract] [Full Text] [Related]

  • 17. Effects of ribosomal associated protein hnRNP D in gemcitabine-resistant pancreatic cancer.
    Wang C, Huang H.
    Biochem Biophys Res Commun; 2021 Nov 19; 579():181-187. PubMed ID: 34624736
    [Abstract] [Full Text] [Related]

  • 18. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
    Dhar D, Raina K, Kumar D, Wempe MF, Bagby SM, Pitts TM, Orlicky DJ, Agarwal C, Messersmith WA, Agarwal R.
    Mol Carcinog; 2020 Oct 19; 59(10):1227-1240. PubMed ID: 32816368
    [Abstract] [Full Text] [Related]

  • 19. Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.
    Chen S, Wang Y, Zhang WL, Dong MS, Zhang JH.
    Mol Med Rep; 2017 Apr 19; 15(4):1461-1470. PubMed ID: 28259943
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.